Title | Allopurinol - Drug Card |
---|---|
Author | Kaylee Campbell |
Course | Nursing Pharmacology |
Institution | University of West Florida |
Pages | 2 |
File Size | 78.2 KB |
File Type | |
Total Downloads | 60 |
Total Views | 139 |
Drug Card ...
Nursing Program Generic Name: Allupurinol
Routes PO
Doses 600 - 800 mg/day
IV 200 – 400 mg/m2/day
Trade Names: Aloprim, Lopurim, Zyloprim
Frequency/Times 2-3 divided doses/1-2 days before chemotherapy or radiation
Single dose or in divided doses q 8-24 hr.
Medication Portfolio Pharmacologic Classification: Xanthine oxidase inhibitors
Therapeutic Classification: Antigout agents, Antihyperuricemics
Action/Purpose
Major Side Effects
Nursing Interventions
Labs
Action:
Most frequent: Rash (discontinue immediately)
Pre Med Administration:
Serum and urine uric acid levels usually begin to lower in 2 -3 days after initiation of oral therapy.
Inhibits the production of uric acid by inhibiting the action of xanthine oxidase.
CV: Hypotension, Flushing, Hypertension, Bradycardia, and HF CNS: Drowsiness GI: Diarrhea, hepatitis, nausea, and vomiting
Monitor intake and output ratios. Decreased kidney function can cause drug accumulation and toxic effects. Ensure that patient maintains adequate fluid intake to minimize risk of kidney stone formation. Assess patient for rash or more severe hypersensitivity reactions. Discontinue immediately if rash occurs. Post Med Administration:
Purpose:
GU: Renal failure, hematuria
Lowering of serum uric acid levels
Hemat: Bone marrow depression Misc: Hypersensitivity reactions
Monitor blood glucose in patients receiving oral hypoglycemic agents. May cause hypoglycemia. Monitor hematologic, renal, and liver function tests before and periodically during therapy, especially during the first few months. May cause high serum alkaline
phosphatase, bilirubin, AST, and ALT levels. Lower CBC and platelets may indicate bone marrow depression....